File: '\\swfile\EmailIn\20250825 140813 Attachment THC News Release Licence Renewal 1410-0116-0216 v.1.docx'

1410-0116-0216, v. 1

THC BIOMED INTL LTD.

P.O. Box 20033 Towne Centre

Kelowna, B.C. V1Y 9H2

www.thcbiomed.com

THC BioMed Receives Health Canada License Renewal to August 2026

KELOWNA, August 25, 2025 - THC BioMed Intl Ltd. ("THC BioMed") or (the "Company"), one of Canada's original, licensed cannabis producers, is pleased to announce that Health Canada has renewed the Company's cannabis cultivation and processing license until August 2026.

This renewal confirms THC BioMed's continued compliance with Health Canada's regulatory requirements and reinforces the Company's commitment to providing safe, high-quality cannabis products to Canadian consumers.

"We are proud to have our license renewed by Health Canada, extending our ability to cultivate, process, and distribute cannabis products to August 2026." said John Miller. "This renewal underscores the integrity of our operations and our ongoing dedication to innovation, compliance, and providing Canadians with accessible cannabis options."

The license renewal allows THC BioMed to continue expanding its product lines, including THC Kiss, one of Canada's longest-standing cannabis beverages, and its portfolio of dried flower, pre-rolls, and clones.

About THC Biomed:

THC Biomed is a leading cannabis company dedicated to producing high-quality, diverse cannabis products. With a focus on innovation and consumer satisfaction, THC Biomed strives to meet the evolving needs of cannabis enthusiasts through continuous research, development, and product excellence. The Company remains focused on innovation in genetics, cultivation, and AI-driven automation as part of its vision for the future of cannabis production.

For more information, contact:

John Miller, CEO

THC BioMed Intl Ltd.

T: 1-844-THCMEDS

E: info@thcbiomed.com

Forward-Looking Information:

This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of THC BioMed. Forward-looking information is based on certain key expectations and assumptions made by the management of THC BioMed. In some cases, you can identify forward-looking statements using words such as "will," "may," "would," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "could" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Although THC BioMed believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because THC BioMed can give no assurance that they will prove to be correct. THC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.